Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$21.69 - $28.53 $338,038 - $444,640
15,585 New
15,585 $374,000
Q2 2021

Aug 26, 2021

SELL
$16.45 - $24.06 $365,634 - $534,781
-22,227 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$18.66 - $29.16 $242,337 - $378,700
12,987 Added 140.55%
22,227 $439,000
Q4 2020

Feb 09, 2021

BUY
$26.57 - $51.74 $245,506 - $478,077
9,240 New
9,240 $246,000

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.19B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Penn Mutual Asset Management, LLC Portfolio

Follow Penn Mutual Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Mutual Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Mutual Asset Management, LLC with notifications on news.